alexa
Reach Us +1-845-458-6882

GET THE APP

Marine Actinomycetes: A Source of Novel Therapeutic Drugs | OMICS International
ISSN: 2155-9910
Journal of Marine Science: Research & Development

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Marine Actinomycetes: A Source of Novel Therapeutic Drugs

Nagendra Sastry Yarla*

Department of Biochemistry and Bioinformatics, School of Life Sciences, GITAM Institute of Science, GITAM University, Visakhapatnam, India

*Corresponding Author:
Nagendra Sastry Yarla
Department of Biochemistry and Bioinformatics
School of Life Sciences, GITAM Institute of Science
GITAM University, Visakhapatnam, India – 530 045
Tel: +91 97016 08894
E-mail: [email protected]

Received date: November 14, 2013; Accepted date: November 15, 2013; Published date: November 22, 2013

Citation: Yarla NS (2013) Marine Actinomycetes: A Source of Novel Therapeutic Drugs. J Marine Sci Res Dev 3:e119. doi: 10.4172/2155-9910.1000e119

Copyright: © 2013 Yarla NS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Marine Science: Research & Development

Marine microorganisms widely distributed on our oceans of the earth and emerging as the great source for the discovery of natural products. Further they are developing as therapeutic agents for various human diseases. Antibacterial [1,2], antifungal [1-3], anti-parasitic [4], antiviral [5], anti-infective [6], insecticidal [4], antitumor [2], antiinflammatory, antioxidant [7] and herbicidal compounds [8] as well as many other compounds are enzyme inhibitors [9] have been isolating from marine actinomycetes. Almost 60% of the antibiotics discovered in the year 1990 and most of the antibiotics (Streptomycin related antibiotics) are from the genus Streptomyces [10].

Marine drugs have been using for various diseases like cancer, typhoid, cholera etc, Hymenialdisine (HMD), a sponge-derived natural product reported as human kinase inhibitors with nanomolar activity. Several antitumor antibiotics like aporphine alkaloids have been isolated from marine actinomycetes. A new macromolecular peptide antibiotic, named AN-1 was isolated from the culture broth of Streptomyces albus AJ 9003 [11]. An antibiotic complex identical to Paulomycins A & B active against multiple resistant strains of staphylococci and other gram-positive bacteria was isolated from cultures of Streptomyces albus G [12]. Salinosporamide A, produced by the marine actinomycete, Salinispora tropica, shows strong inhibitory activity against the erythrocytic stages of the parasite cycle. Biochemical characterization supports the likely inhibition of the parasite 20S proteasome. Several marine-derived compounds used as anticancer agents are undergoing promising preclinical and clinical development. Therefore, the marinederived actinomycetes act as a prominent reservoir for novel drug molecules and answer to several diseases.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 13131
  • [From(publication date):
    December-2013 - Sep 24, 2021]
  • Breakdown by view type
  • HTML page views : 8990
  • PDF downloads : 4141
Top